Home NYT Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense Author - urdu vision June 08, 2021 0 By BY REBECCA ROBBINS AND PAM BELLUCK from NYT Business https://ift.tt/34VvUFX via IFTTT Tags IFTTTNYT Facebook Twitter Whatsapp Newer Older